T1	p 335 357	healthy young subjects
T2	p 431 461	Five groups of 8 subjects each
T3	i 57 107	inhibition of cholesteryl ester transfer protein :
T4	i 138 151	torcetrapib .
T5	i 188 253	cholesteryl ester transfer protein ( CETP ) inhibitor torcetrapib
T6	i 481 488	placebo
T7	i 500 511	torcetrapib
T8	i 592 603	Torcetrapib
T9	i 903 918	CETP inhibition
T10	i 1477 1492	CETP inhibition
T11	o 613 622	tolerated
T12	o 678 727	correlation of plasma drug levels with inhibition
T13	o 833 842	CETP mass
T14	o 903 918	CETP inhibition
T15	o 1001 1025	Total plasma cholesterol
T16	o 1081 1089	nonHDL-C
T17	o 1129 1164	low-density lipoprotein cholesterol
T18	o 1187 1211	Apolipoprotein A-I and E
T19	o 1261 1265	apoB
T20	o 1309 1334	Cholesteryl ester content
T21	o 1349 1361	triglyceride